(2025)
The murine lung microbiome is disbalanced by the human-pathogenic fungus Aspergillus fumigatus resulting in enrichment of anaerobic bacteria.
Cell Rep 44(3),
115442.
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Forschungsschwerpunkte
- Mikrobiom bei Gesundheit und Krankheit
- Systembiologie von Infektionskrankheiten
- Personalisierte Ernährung
Publikationen
(2025)
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease.
Microbiome 13(1),
10.
(2025)
An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial.
Nature Medicine 31(7),
2255-2268.
(2025)
Gut microbiome-adipose crosstalk modulates soluble IL-6 receptor influencing exercise responsiveness in glycemic control and insulin sensitivity.
Cell Metab 37(12),
2323-2341.
(2025)
Targeting protein kinase C-α prolongs survival and restores liver function in sepsis: Evidence from preclinical models.
Pharmacol Res 212,
107581.
(2025)
Chemical pollution drives taxonomic and functional shifts in marine sediment 2 microbiome, influencing benthic metazoans.
ISME Commun 5(1),
ycae141.
(2025)
Multi-omics and -organ insights into energy metabolic adaptations in early sepsis onset.
Adv Sci 12(30),
e04418.
(2025)
Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes.
Nat Microbiol 11(1),
94-110.
(2024)
Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in obese Chinese.
Comput Struct Biotechnol J 23(2024),
791-800.
(2024)
The human gut mycobiome and its potential as a regulator of the host’s metabolic health.
In: Brakhage AA, Kniemeyer O, Zipfel PF (eds.) The Mycota - Human and Animal Relationships 3. 6, pp. 121-133. Springer, Cham.
ISBN: 978-3-031-64852. (Review)